This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MACA Moringa Acquisition (MACA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Moringa Acquisition Stock (NASDAQ:MACA) 30 days 90 days 365 days Advanced Chart Get Moringa Acquisition alerts:Sign Up Key Stats Today's Range$8.91▼$12.0950-Day Range$9.46▼$12.3052-Week Range$8.65▼$13.56Volume59,517 shsAverage Volume7,434 shsMarket Capitalization$36.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York. Read More Receive MACA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moringa Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address MACA Stock News HeadlinesSLXN Silexion Therapeutics CorpNovember 3, 2024 | seekingalpha.comThe best matcha brands to buy in 2024, from ceremonial-grade powders to ready-to-drink cansOctober 28, 2024 | msn.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.August 12 at 2:00 AM | Brownstone Research (Ad)PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven CancersSeptember 9, 2024 | finance.yahoo.comSilexion Therapeutics Corp (SLXN)August 21, 2024 | finance.yahoo.comSilexion Therapeutics, Inc.: Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business CombinationAugust 16, 2024 | finanznachrichten.deSilexion Therapeutics and Moringa Acquisition Corp Announce Closing of their Business CombinationAugust 16, 2024 | finanznachrichten.deBiomotion Sciences Ordinary Shares (SLXN)August 16, 2024 | uk.finance.yahoo.comSee More Headlines Company Calendar Today8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:MACA CIK1835416 Webwww.moringaac.com Phone(212) 572-6395Fax212-572-6395Employees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$260 thousand Net MarginsN/A Pretax MarginN/A Return on Equity-11.33% Return on Assets-2.23% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.05 per share Price / Cash Flow172.16 Book Value($0.74) per share Price / Book-12.78Miscellaneous Outstanding Shares3,870,000Free Float1,769,000Market Cap$36.61 million OptionableNot Optionable Beta0.02 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:MACA) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moringa Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Moringa Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.